GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hydration Pharmaceuticals Co HPC.AX · AUD

Consumer Staples · ASX · 🇦🇺 Australia

Compare

0.00

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$3.2m

FY2018FY2024

Net income

$2.7m

FY2018FY2024

Free cash flow

−$3.9m

FY2018FY2024

Shareholders' equity

$2.7m

FY2018FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$3.2m$4.3m$9.1m$6.1m$3.8m$3.0m$4.2m
Operating income−$4.2m−$6.9m−$10.7m−$6.8m−$3.2m−$3.4m−$9.3m
Net income$2.7m−$8.1m−$10.6m−$9.0m−$743,700−$3.4m−$9.6m
Diluted earnings per share—-0.04-0.06-0.06-0.00-0.02-0.06

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets$5.0m$6.7m$10.4m$15.3m$4.4m$4.2m$4.2m
Cash and short-term investments$3.2m$1.8m$4.7m$10.7m$1.6m$2.7m$2.5m
Total liabilities$2.3m$7.0m$6.4m$2.1m$2.4m$1.8m$1.6m
Debt—$3.9m$3.7m——$2,000$20,800
Shareholders' equity$2.7m−$358,300$4.0m$13.2m$2.0m$2.4m$2.6m
Shares outstanding267m203m168m148m166m161m161m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−$3.9m−$5.7m—−$8.1m−$3.9m−$2.8m−$5.4m
Capital spending————−$18,100−$20,500—
Free cash flow−$3.9m−$5.7m—−$8.1m−$3.9m−$2.8m−$5.4m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
Revenue$1.5m—$1.8m$4.7m$5.3m$5.0m$4.1m$3.8m
Operating income−$1.7m−$1.7m−$2.3m−$3.7m−$4.0m−$5.8m−$4.9m−$4.7m
Net income−$1.4m$5.8m−$3.1m−$4.6m−$3.5m−$6.4m−$4.2m−$6.7m
Diluted earnings per share-0.000.02-0.01-0.02-0.02-0.04-0.03-0.05
Total assets$3.9m$5.0m$5.6m$6.7m$7.4m$10.4m$11.8m$15.3m
Cash and short-term investments$2.1m$3.2m$854,000$1.8m$1.7m$4.7m$6.3m$10.7m
Debt——$4.7m$3.9m$3.7m$3.7m——
Shareholders' equity$2.7m$2.7m−$2.8m−$358,300$432,800$4.0m$9.6m$13.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-19.4%1.6%—
Operating income-15.0%4.3%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-147.4%-125.8%-119.6%—
Net margin-72.4%-109.9%-99.0%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021
Price to earnings1.3-0.4-1.0-3.4
Price to sales1.10.81.15.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.